Navigation Links
New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes
Date:4/23/2010

ons of Use

  • Welchol should not be used for the treatment of type 1 diabetes or for the treatment of diabetic ketoacidosis
  • Welchol has not been studied in type 2 diabetes as monotherapy or in combination with a dipeptidyl peptidase 4 inhibitor and has not been extensively studied in combination with thiazolidinediones
  • Welchol has not been studied in Fredrickson Type I, III, IV, and V dyslipidemias
  • Welchol has not been studied in children younger than 10 years of age or in premenarchal girls

Contraindications

Welchol is contraindicated in individuals with bowel obstruction, those with serum triglyceride (TG) concentrations of >500 mg/dL, or with a history of hypertriglyceridemia-induced pancreatitis.

Warnings and Precautions

The effect of Welchol on cardiovascular morbidity and mortality has not been determined.  

Welchol can increase serum TG concentrations particularly when used in combination with sulfonylureas or insulin. Caution should be exercised when treating patients with TG levels >300 mg/dL.

Welchol may decrease the absorption of fat-soluble vitamins A, D, E and K. Patients on vitamin supplements should take their vitamins at least 4 hours prior to Welchol. Caution should be exercised when treating patients with a susceptibility to vitamin K or fat-soluble vitamin deficiencies.

Caution should also be exercised when treating patients with gastroparesis, gastrointestinal motility disorders, major gastrointestinal tract surgery, and when treating patients with dysphagia and swallowing disorders.

Welchol reduces gastrointestinal absorption of some drugs. Drugs with a known
'/>"/>

SOURCE Daiichi Sankyo
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent
2. Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
3. Adamas Pharmaceuticals TCAD Therapy Demonstrates Broad Spectrum Activity Against Susceptible and Resistant Strains of Influenza in Animal Models
4. New Data Demonstrates Abbotts Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition
5. New Study Demonstrates Safety of Balloon Sinuplasty(TM) Technology in Pediatric Patients Suffering From Chronic Sinusitis
6. Tobiras Next-Generation Once-Daily CCR5 Receptor Antagonist Demonstrates Efficacy, Safety and Tolerability in Treatment-Experienced Patients With HIV
7. NovaShunt Starts its Pivotal Clinical Study "PIONEER" to Demonstrate the Clinical Value of the AFS System
8. Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
9. Elekta Expands Consultative Services Program to Help MOSAIQ Customers Demonstrate Meaningful Use Guidelines
10. AsepticSure(TM) Hospital Sterilization System Demonstrates Total Eradication of Super Bugs
11. Clinical Data Presented at Asia PCR/Sing LIVE Demonstrate Benefits of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) in Challenging Patient Subsets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... SAN JOSE, Calif. , Nov. 26, 2014 ... proprietary technologies to produce novel therapies for infectious ... Opal , M.D., an internationally recognized key opinion ... to the Company,s scientific advisory board. ... , Ph.D., stated, "We believe Dr. Opal,s extensive ...
(Date:11/26/2014)... CHARLOTTE, N.C. , Nov. 25, 2014  At ... San Antonio this October, KaVo Kerr Group ... Institute Technology Expo, offering attendees the opportunity to see ... to well-respected key opinion leaders deliver lectures on the ... Kerr Group products include the new DEXIS CariVu Caries ...
(Date:11/26/2014)... Calif. , Nov. 25, 2014 /PRNewswire/ ... company focused on the development of mobile ... accurate testing in hospital and pre-hospital settings, ... Organization (ISO) 13485:2003 certification.  The certification was ... one of the world,s leading certification bodies. ...
Breaking Medicine Technology:Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Nanomix Receives ISO 13485:2003 Certification 2
... Neurologix, Inc. (OTC Bulletin Board: NRGX ... landmark, randomized, double-blind Phase 2 clinical trial of NLX-P101, ... were presented during a symposium at the 2nd World ... trial, Dr. Peter Lewitt, Director of the Parkinson,s Disease ...
... Oct. 1 Elekta recently launched ABAS ( ... Simultaneous Truth and Performance Level Estimation (STAPLE) algorithm ... standard for autosegmentation accuracy—deforms atlases of anatomy previously ... patient image, creating a new structure set fit ...
Cached Medicine Technology:New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease 2New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease 3New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease 4New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease 5New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease 6New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease 7Elekta Launches ABAS 2.0 Autosegmentation Software Used to Plan Radiation Therapy in Patients With Cancer 2
(Date:11/27/2014)... The report “Blepharitis – Pipeline Review, ... development for Blepharitis, complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ... news and press releases. It also reviews key ... and special features on late-stage and discontinued projects. ...
(Date:11/27/2014)... Turks and Caicos Islands; BWI (PRWEB) November 28, 2014 ... for the Tuscany Resort in the Turks & Caicos. ... resorts by TripAdvisor in Providenciales, is announcing a few ... three bedroom villa rentals. And they are offering ... resort. , Additionally, The Tuscany, is having a ...
(Date:11/27/2014)... Absolute PhysioCare & Sports Rehab, a ... personalized treatment plans, highly skilled and educated therapists ... sports injuries reach pre-injury state. Whether it is ... Absolute Physio has the right treatment for it. ... meniscal injuries, groin strain and sports hernia can ...
(Date:11/27/2014)... 27, 2014 Cambrionix Ltd today announced that ... 50, a ranking of the 50 fastest-growing technology companies in ... over the last five years. Cambrionix Ltd grew 2989 ... first in the region of Cambridgeshire and East and first ... Says:, “This award is recognition of the hard work put ...
(Date:11/27/2014)... 2014 An inventor from Buffalo, N.Y., ... of life, and she wants to lessen its impact. ... I decided that there needed to be a way ... Easy to use and producible in design variations, the ... private areas throughout the day. It avoids bad odors, ...
Breaking Medicine News(10 mins):Health News:Blepharitis Pipeline Market Review on Drugs and Companies H2 2014 2Health News:Blepharitis Pipeline Market Review on Drugs and Companies H2 2014 3Health News:Blepharitis Pipeline Market Review on Drugs and Companies H2 2014 4Health News:The Tuscany on Grace Bay, Top-Rated TripAdvisor Resort in the Turks & Caicos Islands, Offers Special Pre-Christmas & January 2015 Promotions! 2Health News:Coquitlam Physiotherapy Clinic Now Helps Clients Reach Pre-Injury State 2Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 2Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 3Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 4
... Producer ... ... announces the April 13, 2010 release of , in my room , -a multi ... produced by LML recording artist D.C. Anderson , the prolific writer/producer/performer behind the successful ...
... ... ... Human Thriving Foundation is a nonprofit organization whose Mission Statement is: To scientifically increase ... Behavioral Laboratory announces today that it appears that they have Cracked the DNA Code ...
... ... monitoring using mobile networks will rise to almost $1.9 billion globally by 2014, with heart ... , ... 2010 -- According to Juniper Research, revenues from remote patient monitoring using mobile networks will ...
... ... used in MTV’s ‘Jersey Shore’ was a Bullfrog Spa. , ... Salt Lake City, Utah (Vocus) April 13, 2010 -- Ever ... been understandably reluctant to point it out, Bullfrog International is ready to admit that it ...
... ... Muscle Pain Relief. , ... (Vocus) April 13, 2010 -- Susan Z. Robins, President of ... in January 2010. The response was overwhelmingly positive and Muscle Angel Massagers™ were ...
... ... range of Intacs to benefit patients suffering from keratoconus , ... (Vocus) April 12, 2010 -- Khanna Institute will now be ... the announcement by the maker of Intacs corneal implants Addition Technology, Inc., that it has ...
Cached Medicine News:Health News:Peter Bradley Adams, Victoria Shaw, Many Distinguished Colleagues Ally To Benefit National MS Society With CD Release: In My Room 2Health News:Peter Bradley Adams, Victoria Shaw, Many Distinguished Colleagues Ally To Benefit National MS Society With CD Release: In My Room 3Health News:Peter Bradley Adams, Victoria Shaw, Many Distinguished Colleagues Ally To Benefit National MS Society With CD Release: In My Room 4Health News:Behavioral Laboratory Cracks the DNA Code of Happiness 2Health News:Revenues from Mobile Health Monitoring to Reach $1.9 Billion Globally by 2014 Says Juniper Research 2Health News:Revenues from Mobile Health Monitoring to Reach $1.9 Billion Globally by 2014 Says Juniper Research 3Health News:The Identity of the Jersey Shore Hot Tub Revealed 2Health News:Muscle Angel Massagers™ Receive Accolades from Dentists and Hygienists 2Health News:Muscle Angel Massagers™ Receive Accolades from Dentists and Hygienists 3Health News:Muscle Angel Massagers™ Receive Accolades from Dentists and Hygienists 4Health News:Muscle Angel Massagers™ Receive Accolades from Dentists and Hygienists 5Health News:Khanna Institute to Offer Newly FDA Approved Expanded Range of Intacs for Keratoconus 2Health News:Khanna Institute to Offer Newly FDA Approved Expanded Range of Intacs for Keratoconus 3
Zone Quick is a simple and accurate system that measures tear volume in just 15 seconds per eye. Each box has an easy to read diagnostic indicator rule....
... been introduced by FCI Ophthalmics, Inc. Designed by ... addressed the limitations previously encountered with balloon catheter ... in to position through the nose, it has ... need to pass the very large diameter end ...
... the heart of the Diagnosys electrophysiology system is ... allowing it to support a wide variety of ... , Clinical Function Testing ,The Espion ... easily perform all the current standard clinical visual ...
... are not restricted to small central ... These are full field capable, all ... perimeters you'll ever need to ensure ... They also include the most ...
Medicine Products: